# Contact Legal Sermorelin: Editorial Inquiries on the Sermorelin Digest

> Contact Legal Sermorelin with editorial questions or corrections about our cited sermorelin research summaries. Editorial inquiries only; no medical advice, no sales.

Editorial questions and corrections about our sermorelin research summaries are welcome.

## Editorial inquiries

Use the form below for editorial questions, source suggestions, or corrections to our sermorelin coverage. We read every message about the accuracy of a citation, a figure, or an attribution — if a study has been misread, a number transcribed wrong, or a newer reference belongs on the board, tell us and we will check it against the source and correct the record. We are particularly glad to hear when a body-composition result has been attributed to GHRH(1-29) where it actually belongs to a stabilized analog, since that is the distinction this site works hardest to keep straight.

## What we cannot help with

We are an editorial publisher, not a clinic and not a vendor. We cannot provide medical advice, interpret personal lab results, recommend or adjust a dose, or discuss obtaining, pricing, or sourcing any product — and we will not, no matter how the question is phrased. Questions of that kind belong with a qualified healthcare professional who can account for an individual's history, not with an editorial project that summarizes published research. Nothing here is dispensed, prescribed, or sold, and no message to us creates a clinical relationship of any kind.

## Send a message

Provide a name, an email address, and your message. We reply to editorial correspondence about the published research and the way it is summarized on this site. If your note concerns a specific claim, a link to or citation for the study in question helps us respond accurately and quickly.

## Our corrections policy

Accuracy is the whole value of a research digest, so corrections are taken seriously and acted on promptly. If a citation points to the wrong paper, a figure has been transcribed incorrectly, or a finding has been attributed to GHRH(1-29) when it belongs to a stabilized analog such as tesamorelin, we will verify the point against the primary source and update the page. We would rather fix a small error quickly than let it stand, and we acknowledge substantive corrections where the sender wishes. This site exists to summarize what the studies measured; keeping that summary faithful to the sources is the standard we hold ourselves to, and reader scrutiny is part of how we meet it.

---

The sermorelin record filed cell by cell on a research board — every GH and IGF-1 figure carried back to its study, the body-composition evidence marked as tesamorelin where it belongs, and the empty long-term-safety cell left openly unfilled; no clinic behind the board and nothing here dosed, dispensed, or sold.